MUTO Akihiro

J-GLOBAL         Last updated: Mar 22, 2016 at 11:58
 
Avatar
Name
MUTO Akihiro
Affiliation
Hoshi University
Job title
Associate Professor
Other affiliation
Keio University

Research Areas

 
 

Published Papers

 
Yamaguchi SI, Ueki A, Sugihara E, Onishi N, Yaguchi T, Kawakami Y, Horiuchi K, Morioka H, Matsumoto M, Nakamura M, Muto A, Toyama Y, Saya H, Shimizu T
Cancer science   106(7) 875-882   Jul 2015   [Refereed]
Shimizu T, Sugihara E, Yamaguchi-Iwai S, Tamaki S, Koyama Y, Kamel W, Ueki A, Ishikawa T, Chiyoda T, Osuka S, Onishi N, Ikeda H, Kamei J, Matsuo K, Fukuchi Y, Nagai T, Toguchida J, Toyama Y, Muto A, Saya H
Cancer research   74(22) 6531-6541   Nov 2014   [Refereed]
Ueki A, Shimizu T, Masuda K, Yamaguchi SI, Ishikawa T, Sugihara E, Onishi N, Kuninaka S, Miyoshi K, Muto A, Toyama Y, Banno K, Aoki D, Saya H
PloS one   7(11) e50621   2012   [Refereed]
Nakaya A, Sagawa M, Muto A, Uchida H, Ikeda Y, Kizaki M
Leukemia research   35(2) 243-249   Feb 2011   [Refereed]

Misc

 
Arsenic trioxide (As203)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice
Leukemia   14(3) 431-438   2000
Establishiment of a retinoic acid-resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM-CSF) transgenic severe combined immunodeficiency (SCID) mice
British Journal of Cancer   78(7) 878-884   1998
Establishment and characterization of a novel acute prolymphocytic leukemia cell line (UF-1) with retinoic acid-resistant features
Blood   88(5) 1824-1833   1996
Retinoids have direct effects on megakaryopoiesis and differentiate a megakaryoblastic leukemia cell line in combination with thrombopoietin
第38回Annual Meeting of American Society of Hematology      1996
Establishment and characterization of a novel acute promyelocytic cell line (UF-1) with retinoic acid resistant features
第37回Annual Meeting of the American Society of Hematology      1995
Recovery of drug sensitivity in retinoic acid-resistant leukemic cells by MDR1 ribozymes
第38回Annual Meeting of American Society of Hematology      1996
Combination of GM-CSF and arsenic trioxide induces differentiation, but not apoptosis, in APL cells by modulating Jak2 kinase and Mcl-1 protein
International Conference on Differentiation Therapy (8th ; 1999 ; Montreal)      1999
Establishment of a retinoic acid resistant human APL model in hGM-CSF transgenic scid mice and their application to the in vivo study of arsenic trioxide (As2O3)
The American Society of Hematology : Annual Meeting (39th; 1997; San Diego)      1997
Induction of apoptosis in myeloid leukemic cells by ribozymes targeted against AML1/MTG8
Annual Meeting of American Society of Cancer Research (90th ; 1999 ; Philadelphia)      1999
Establishment of a retinoic acid resistant human APL model in hGM-CSF transgenic SCID mice
American Assciation for Cancer Research (89th; 1997; New Orleans)      1998
Establishment and characterization of a novel acute promyelocutic leukemia cell line (UF-1) with retinoic acid resistant features
第37回American Society of Hematology      1995
GM-CSF and arsenic trioxide (AszO3) induce differentiation, but not apoptosis, of retinoic acid (RA)-resistant APL in vivo and in vitro by modulating Jak2 tyrosine kinase and bax
Annual Meeting of the American Society of Hematology (40th; 1998; Miami)      1998
Differentiation and growth arrest of retinoic acid-retinoic acid-resistant APL cell line (UF-1) by 1,25α-dihydroxyvitamin D3 through the activation of cdk inhibitors
American Association for Cancer Research(88th; 1997; Sam Diego)      1997
1,25-dihydroxyvitamin D3 induces differentiation of retinoic acid-resistant APL cell line (UF-1) via activated cycline-dependent kinase inhibitors
第38回Annual Meeting of American Society of Hematology      1996
1,25-Dihydroxyvitamin D3 induces differentiation of retinoic acid-resistant APL cell line (UF-1) via activated cycline-dependent kinase inhibitors
第38回 American Society Hematology      1996
Development and clinical evaluation of quantification of the minimal residual disease in t (8 ; 21) leukemia with novel RT-competitive PCR assay
第37回Annual Meeting of the American Society of Hematology      1995
Ribozymes cleave AML1/MTG8 transcript and inhibit the proliferation of leukemic cells with t (8 ; 21)
第37回Annual Meeting of the American Society of Hematology      1995
A novel mutation in the cytoplasmic domain of G-CSF receptor gene in MDS : Relationship with the proliferative reponse to G-CSF and its transforming potential
The American Society of Hematology : Annual Meeting (39th; 1997; San Diego)      1997

Research Grants & Projects

 
-